November, 2024

article thumbnail

The recovery community says it offers refuge from opioid addiction. But it’s still hostile to lifesaving addiction medications 

STAT

The last time Mark Palinski went to a Narcotics Anonymous meeting, he was asked to leave and never come back. He stills remembers the argument: All he had done was advocate for the use of the “gold standard” treatment opioid addiction, a common medication called buprenorphine.  To Palinski, buprenorphine is a godsend.

363
363
article thumbnail

Turning Loss into Purpose: My Journey to a Pharmacy Career to Make a Difference

Pharmacy Is Right For Me

Meet Lila, a passionate fourth-year Pharm.D. student at Auburn University Harrison College of Pharmacy. During her APPE rotation with the American Association of Colleges of Pharmacy , Lila opened up about her inspiring journey to find the perfect pharmacy school and how, with the guidance of mentors, she discovered her true “Pharmily.” How did you choose your pharmacy school/college or graduate program?

230
230
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHSE urged to commission pharmacy vaccinations

The Pharmacist

NHS England (NHSE) should commission community pharmacies to deliver a wider range of NHS vaccines including pneumonia, shingles, meningitis, RSV and routine childhood vaccinations, the Company Chemists' Association (CCA) has said. It noted that many pharmacies already offer these vaccines privately, and suggested that commissioning NHS vaccinations through community pharmacies could improve uptake in historically […] The post NHSE urged to commission pharmacy vaccinations appeared first o

Vaccines 124
article thumbnail

Spravato is just the beginning in a new wave of depression meds

PharmaVoice

Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.

318
318
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth

Express Pharma

Key Findings: 75 per cent pharma leaders emphasise the need for sustainable manufacturing practices Highlight digital integration as crucial for improving healthcare access 63 per cent CXOs cite the need for a single global product standard 50 per cent believe regulatory simplification and streamlining will drive growth EY Parthenon (EY-P) in partnership with the Organisation of Pharmaceutical Producers of India (OPPI), released a report titled ‘Viksit Bharat@2047: Transforming India from pharma

More Trending

article thumbnail

Opinion: The FDA’s risky action on compounding weight loss drugs

STAT

When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash. The drug was based on an active ingredient that had been available for many years at a much lower cost. Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.

article thumbnail

Managing Drug Patent Portfolios Effectively

Drug Patent Watch

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

article thumbnail

Pharmacy owners vote overwhelmingly in favour of collective action

The Pharmacist

Pharmacy owners in England, Wales and Northern Ireland have voted in favour of taking collective action, according to a ballot carried out by the National Pharmacy Association (NPA). Some 99% of participating pharmacy owners said they were willing to limit their services unless funding is improved. The NPA said that subject to agreement from its […] The post Pharmacy owners vote overwhelmingly in favour of collective action appeared first on The Pharmacist.

131
131
article thumbnail

CEO with type 1 diabetes works to deliver ‘world’s first’ functional cure

PharmaVoice

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

Diabetes 313
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Incubators and innovation hubs: Accelerating entrepreneurship in life sciences

Express Pharma

“The first wealth is health,” said the American philosopher Ralph Waldo Emerson in 1860, and strides in life sciences entrepreneurship pronouncedly affect this form of wealth in any country. In India, the life sciences innovation, which includes pharma, biotech, and medtech, is valued at $30 billion in 2024. The country’s health metrics, such as the growing burden of non-communicable diseases, rising life expectancy, malnutrition, and air pollution, present a further scope for innovations

article thumbnail

GLP-1 receptor agonists aid broader outcomes in kidney disease, major analysis finds

European Pharmaceutical Review

Glucagon-like peptide-1 (GLP-1) receptor agonists have shown to provide meaningful benefits in chronic kidney disease (CKD) and individuals with and without diabetes. This based on the largest, most comprehensive analysis of GLP-1 antagonists on kidney and cardiovascular outcomes. While GLP-1 receptor agonists have shown benefit for type 2 diabetes, obesity and cardiovascular disease, its impact as a treatment in chronic kidney disease is not as clear, the researchers explained.

article thumbnail

STAT+: BridgeBio wins FDA approval for heart disease drug

STAT

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart disease — the first new treatment for the condition in over five years and the company’s first significant commercial product. The drug, known scientifically as acoramidis, will be sold by BridgeBio under the brand name Attruby.

357
357
article thumbnail

Can drugs be blockbusters without relying on US sales?

Drug Patent Watch

The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S. sales.

98
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Study shows benefits of pharmacy sore throat service over GP consultation

The Pharmacist

A pharmacy-led sore throat treatment service in Wales has been found to result in fewer same-day antibiotic prescriptions than those given during GP consultations, according to a new study. The study, published in the Journal of Antimicrobial Chemotherapy, found that pharmacy-led sore throat treatment provides a safe, effective, and cost-efficient alternative to GP consultations.

article thumbnail

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

PharmaVoice

A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won’t be the first to market.

291
291
article thumbnail

Pharma dose CMOs face growth slowdown, but opportunities lie ahead

Express Pharma

Contract manufacturing revenues in the pharmaceutical finished dose sector witnessed a significant slowdown over the past financial year. Challenging market conditions, driven by drug pricing pressures, regulatory shifts, and geopolitical tensions, have reshaped the landscape, offering both hurdles and opportunities for contract manufacturing organisations (CMOs) to adapt and innovate amidst global generic shortages, reveals GlobalData.

article thumbnail

J&J seek approval for first drug to treat high-risk smoldering myeloma

Pharmafile

Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the European Medicines agency (EMA) for the approval of a new indication for DARAZALEX FASPRO (daratumumab and hyluronidase-fihj). DARAZLEX FASPRO would be used as a monotherapy for the treatment of high-risk smoldering multiple myeloma in adult […] The post J&J seek approval for first drug to treat high-risk smoldering myeloma appeared first on Pharmafile.

102
102
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

What really happens to drug prices when patents expire

STAT

This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market. Lower prices are good news for patients seeking more affordable medications, but the change can sometimes take a while.

article thumbnail

Patient Centricity in Generic Drug Development: Best Practices

Drug Patent Watch

Patient centricity has become a crucial aspect of the pharmaceutical industry, particularly in the development of generic drugs. This approach focuses on understanding and addressing the needs and preferences of patients to ensure that the medications they receive are safe, effective, and easy to use.

article thumbnail

Cytisine pill could be added to stop smoking guidelines

The Pharmacist

NICE is consulting on a proposal to add cytisine as a treatment option to its stop smoking guidelines. This proposal follows a review of recent evidence which suggests patients who received cytisine were 30% more likely to not smoke for six months or longer, when compared to placebo or no medication. The drug was made […] The post Cytisine pill could be added to stop smoking guidelines appeared first on The Pharmacist.

114
114
article thumbnail

An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond

PharmaVoice

Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.

279
279
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Soft launch of first indigenous antibiotic to combat AMR, Nafithromycin, announced by Dr Jitendra Singh

Express Pharma

Union Minister Dr Jitendra Singh formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections. It is only after 2014, when Prime Minister Narendra Modi took over that our researchers received the right kind of support to explore their potential, said Dr Jitendra Singh. The antibiotic Nafithromycin has been developed with the support of the Biotechnology Industry Research Assistance Council (BIRAC), a unit of the Department of Biotechnology and has been brought to ma

Diabetes 105
article thumbnail

Bipolar disorder: how lithium as a treatment fell out of favour

The Guardian - Pharmaceutical Industry

As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition Occupational stress is a trigger for Rebecca Wilde, a 32-year-old tech worker in Buckinghamshire. Four years ago, work pressures combined with family issues affected her sleep, leading to a severe manic episode.

110
110
article thumbnail

STAT+: How Pfizer used wearables to tap into the promise of an experimental drug

STAT

Pfizer’s promising research on a treatment for a dangerous cancer-related condition is also helping prove out the value of wearables in clinical trials. In September, the pharma giant reported results showing that an experimental antibody could positively impact people with cachexia, a complication sometimes called “wasting syndrome” that can cause people with cancer to lose weight and make it harder for them to tolerate treatments.

338
338
article thumbnail

The Future of Generic Drug Development in Emerging Markets

Drug Patent Watch

The pharmaceutical industry is undergoing a significant shift, with emerging markets offering the next growth opportunity. This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Call for government strategy to tackle 'devastating impact' of medicines shortages

The Pharmacist

The government has been urged to intervene over the ‘devastating’ and ‘growing’ impact of medicines shortages across the UK. Some 20 pharmacy and patient groups have written to health and social care secretary Wes Streeting calling for a ‘cohesive cross-government’ strategy that would help strengthen the medicines supply chain and better protect access to medicines. […] The post Call for government strategy to tackle 'devastating impact' of medicines shortages appeared first on T

article thumbnail

What RFK Jr.’s influence could mean for pharma

PharmaVoice

Past comments hint at the changes Robert F. Kennedy Jr. could make across the various sectors of healthcare.

280
280
article thumbnail

Dr. Reddy’s launches Toripalimab under the brand name Zytorvi in India

Express Pharma

Dr. Reddy’s Laboratories announced the launch of Toripalimab, immuno-oncology drug in India. Toripalimab is a New Biological Entity (NBE). It is approved by various regulatory authorities around the world such as the United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), Medicines and Healthcare Products Regulatory Agency (MHRA), and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).